Onbo subcutaneous injection 100mg autoinjector, from Eli Lilly Japan, contains mirikizumab (genetical recombination). This IL-23 inhibitor is used for the treatment of moderate-to-severe active ulcerative colitis and Crohn’s disease in adults. It is supplied as 100mg x 1mL kit with YJ code 2399407G2020.
Onbo subcutaneous injection 100mg autoinjector
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →